The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial

MLA

Jeng-Fu Yang, et al. “The Efficacy and Safety of Pegylated Interferon plus Ribavirin Combination Therapy in Chronic Hepatitis c Patients with Hepatocellular Carcinoma Post Curative Therapies – A Multicenter Prospective Trial.” Journal of Hepatology, vol. 54, Feb. 2011, pp. 219–26. EBSCOhost, https://doi.org/10.1016/j.jhep.2010.07.011.

APA

Jeng-Fu Yang, Nai-Jen Hou, Jee-Fu Huang, Ming-Lung Yu, Ching-I Huang, Chang-Fu Chiu, Ming-Yen Hsieh, Zu-Yau Lin, Ming-Lun Yeh, Shinn-Cherng Chen, Wan-Long Chuang, Chia-Yen Dai, Chung-Feng Huang, & Liang-Yen Wang. (2011). The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial. Journal of Hepatology, 54, 219–226. https://doi.org/10.1016/j.jhep.2010.07.011

Chicago

Jeng-Fu Yang, Nai-Jen Hou, Jee-Fu Huang, Ming-Lung Yu, Ching-I Huang, Chang-Fu Chiu, Ming-Yen Hsieh, et al. 2011. “The Efficacy and Safety of Pegylated Interferon plus Ribavirin Combination Therapy in Chronic Hepatitis c Patients with Hepatocellular Carcinoma Post Curative Therapies – A Multicenter Prospective Trial.” Journal of Hepatology 54 (February): 219–26. doi:10.1016/j.jhep.2010.07.011.